Chemotherapy Induced Peripheral Neuropathy – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Chemotherapy Induced Peripheral Neuropathy – Drugs In Development, 2024 report and make more profitable business decisions.
Chemotherapy-induced peripheral neuropathy (CIPN) is a side effect of cancer treatment. Symptoms include pain, burning, tingling, constipation, muscle weakness, blood pressure changes, and balance problems. Risk factors include longer duration of therapy, pre-existing neuropathy, and type of chemotherapeutic agent.
The Chemotherapy Induced Peripheral Neuropathy drugs in development market research report provide comprehensive information on the therapeutics under development for Chemotherapy Induced Peripheral Neuropathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Chemotherapy Induced Peripheral Neuropathy and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Chemotherapy Induced Peripheral Neuropathy | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 62 molecules, with 58 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Chemotherapy Induced Peripheral Neuropathy therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Chemotherapy Induced Peripheral Neuropathy pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Chemotherapy Induced Peripheral Neuropathy treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Abalone Bio IncAchelios Therapeutics Inc
Algenis
AlgoTherapeutix SAS
Amniotics AB
Annji Pharmaceutical Co Ltd
Apexian Pharmaceuticals Inc
Aphios Corp
Artelo Biosciences Inc
Asahi Kasei Pharma Corp
Augustine Therapeutics
Avantyx Pharmaceuticals LLC
AxoProtego Therapeutics LLC
Beijing 3E-Regenacy Pharmaceuticals Co Ltd
Bexion Pharmaceuticals Inc
Bright Minds Biosciences Inc
Bristol-Myers Squibb Co
CAMP Therapeutics Inc
Candel Therapeutics Inc
Daiichi Sankyo Co Ltd
EA Pharma Co Ltd
Eikonizo Therapeutics Inc
Eli Lilly and Co
Exodos Life Sciences Limited Partnership
Eydis Bio Inc
Grunenthal GmbH
Hallym University
Helsinn Healthcare SA
Hoba Therapeutics ApS
Immunophage Biotech Co Ltd
Institute of Biotechnology and Pharmaceutical Research
Jiangsu Hengrui Medicine Co Ltd
LTT Bio-Pharma Co Ltd
MAKScientific LLC
MediciNova Inc
Medifron DBT Co Ltd
Mundipharma International Ltd
Navega Therapeutics Inc
NeurExo Sciences LLC
Neuropathix Inc
NeuroTherpia Inc
Novaremed AG
Nura Bio Inc
OliPass Corporation
Ono Pharmaceutical Co Ltd
Osmol Therapeutics Inc
PharmatrophiX Inc
Regenacy Pharmaceuticals LLC
Regulonix LLC
Rudacure Co Ltd
Senzer Ltd
Serpin Pharma LLC
SiteOne Therapeutics Inc
Solasia Pharma KK
Sonnet BioTherapeutics Holdings Inc
Sova Pharmaceuticals Inc
Synerkine Pharma BV
Trevena Inc
University of Strasbourg
WEX Pharmaceuticals Inc
Winsantor Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Chemotherapy Induced Peripheral Neuropathy reports